PL3253395T3 - Preparat probiotyczny do leczenia zapalenia jelit - Google Patents

Preparat probiotyczny do leczenia zapalenia jelit

Info

Publication number
PL3253395T3
PL3253395T3 PL16703837.1T PL16703837T PL3253395T3 PL 3253395 T3 PL3253395 T3 PL 3253395T3 PL 16703837 T PL16703837 T PL 16703837T PL 3253395 T3 PL3253395 T3 PL 3253395T3
Authority
PL
Poland
Prior art keywords
probiotic preparation
gut inflammation
treating gut
treating
inflammation
Prior art date
Application number
PL16703837.1T
Other languages
English (en)
Inventor
Barry Smith
Robert Broadbent
Original Assignee
Multigerm Uk Enterprises Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multigerm Uk Enterprises Ltd. filed Critical Multigerm Uk Enterprises Ltd.
Publication of PL3253395T3 publication Critical patent/PL3253395T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16703837.1T 2015-02-05 2016-02-05 Preparat probiotyczny do leczenia zapalenia jelit PL3253395T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1501938.3A GB201501938D0 (en) 2015-02-05 2015-02-05 Probiotic preparation
PCT/GB2016/050269 WO2016124940A1 (en) 2015-02-05 2016-02-05 Probiotic preparation for treating gut inflammation

Publications (1)

Publication Number Publication Date
PL3253395T3 true PL3253395T3 (pl) 2026-02-09

Family

ID=52746195

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16703837.1T PL3253395T3 (pl) 2015-02-05 2016-02-05 Preparat probiotyczny do leczenia zapalenia jelit

Country Status (5)

Country Link
EP (2) EP4696375A3 (pl)
ES (1) ES3056399T3 (pl)
GB (1) GB201501938D0 (pl)
PL (1) PL3253395T3 (pl)
WO (1) WO2016124940A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201501938D0 (en) * 2015-02-05 2015-03-25 Multigerm Uk Entpr Ltd Probiotic preparation
CA3085456A1 (en) * 2017-12-14 2019-06-20 Pure Cultures 2020, Inc. Probiotics and fermentation metabolites for the prevention and treatment of disease conditions in animals
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
BR112020018047A2 (pt) * 2018-03-05 2020-12-22 Bio-K Plus International Inc. Métodos para o alívio de um distúrbio gastrointestinal e da síndrome do intestino irritável e para melhorar a qualidade de vida de um indivíduo que sofre de síndrome do intestino irritável, método alternativo à terapia com fármacos para a prevenção e/ou tratamento da síndrome do intestino irritável, composições para o alívio de um distúrbio gastrointestinal e da síndrome do intestino irritável, e, uso de uma combinação
EP3846830A4 (en) 2018-09-05 2022-07-06 Solarea Bio, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
GB2418431A (en) * 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
CA2622951A1 (en) * 2005-09-28 2007-04-05 Nordisk Rebalance A/S Treatment of ibd and ibs using both probiotic bacteria and fermented cereal as treatment effectors
CA2784723C (en) * 2009-12-22 2021-01-12 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
EP3329927B1 (en) * 2011-11-16 2023-09-27 Multigerm UK Enterprises Ltd. Ibs treatment with probiotics
GB201501938D0 (en) * 2015-02-05 2015-03-25 Multigerm Uk Entpr Ltd Probiotic preparation

Also Published As

Publication number Publication date
EP3253395A1 (en) 2017-12-13
EP3253395C0 (en) 2025-10-29
EP3253395B1 (en) 2025-10-29
EP4696375A2 (en) 2026-02-18
GB201501938D0 (en) 2015-03-25
ES3056399T3 (en) 2026-02-20
WO2016124940A1 (en) 2016-08-11
EP4696375A3 (en) 2026-05-13

Similar Documents

Publication Publication Date Title
IL255780A (en) Therapeutic combinations and methods for treating neoplasia
ZA201705673B (en) Methods for treating skin
IL253803A0 (en) A preparation for the treatment of hypothyroidism
SG11201705093UA (en) Composition for treating il-6-related diseases
SG11201802794PA (en) Therapeutic compounds and methods
PT3189074T (pt) Composições e métodos para tratar e prevenir a inflamação
IL254393A0 (en) Methods for treating diseases associated with pathological changes in protein
GB201502137D0 (en) Treatment
GB201522243D0 (en) Treatment
SG11201801103SA (en) Sleeping apparatus
SG11201607440YA (en) Composition and method for enhancing wound healing
GB201501938D0 (en) Probiotic preparation
IL254963A0 (en) Preparations and methods for the treatment of autism
ZA201605667B (en) Implant comprising fgf-18
GB201519450D0 (en) Novel treatment
GB201508841D0 (en) Treatment
SG11201802292UA (en) Composition for treating pain
GB201503008D0 (en) Treatment
GB201513188D0 (en) Method of tomography
ZA201802201B (en) Novel formulation and treatment methods
IL252707B (en) Compositions and methods for treating diseases
SG11201706885RA (en) Novel treatment method
PL3129031T3 (pl) Kompozycja do terapii zaburzeń żołądkowych
GB201512139D0 (en) Methods of treatment
ZA201805215B (en) Preparation for nasal-nasopharyngeal treatment